Experimental Validation: In vitro experiments confirmed that Diosgenin inhibits GC cell proliferation, migration, and invasion, while Western blot analysis validated its modulation of key proteins (MDM2, p53, and PLK1). The gene discussed is PLK1; the disease is gastric cancer.